Toxicity of liposomal N-acyl daunorubicins to L929 cells in culture.
作者信息
Bard D R, Knight C G, Page-Thomas D P
出版信息
Br J Cancer. 1982 May;45(5):783-5. doi: 10.1038/bjc.1982.121.
Abstract
摘要
相似文献
1
Toxicity of liposomal N-acyl daunorubicins to L929 cells in culture.
Br J Cancer. 1982 May;45(5):783-5. doi: 10.1038/bjc.1982.121.
2
Syntheses and biological activities of daunorubicin analogs with uncommon sugars.
Bioorg Med Chem. 2005 Dec 1;13(23):6381-7. doi: 10.1016/j.bmc.2005.06.053. Epub 2005 Aug 1.
3
Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells.
Exp Hematol. 2011 Jul;39(7):741-50. doi: 10.1016/j.exphem.2011.04.001. Epub 2011 Apr 9.
4
Intracellular uptake of 7-con-o-methylnogarol and adriamycin by cells in culture and its relationship to cell survival.
Cancer Res. 1981 Mar;41(3):882-7.
5
Liposome encapsulated daunorubicin doubles anthracycline toxicity in cell lines showing a non-PGP related multidrug resistance.
Haematologica. 1999 Dec;84(12):1151-2.
6
p-Benzylthiocarbamoyl-aspartyl-daunorubicin-substituted polytrisacryl. A new drug acid-labile arm-carrier conjugate.
Eur J Biochem. 1988 Oct 1;176(3):625-8. doi: 10.1111/j.1432-1033.1988.tb14322.x.
7
Hormone-drug conjugates.
Methods Enzymol. 1985;112:259-69. doi: 10.1016/s0076-6879(85)12022-7.
8
[Acute toxicity of the N-acyl derivatives of carminomycin and rubomycin].
Antibiotiki. 1982 Jan;27(1):57-61.
9
The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers.
J Liposome Res. 2012 Jun;22(2):168-76. doi: 10.3109/08982104.2012.668552. Epub 2012 Mar 19.
10
Association of daunorubicin to a lipid nanoemulsion that binds to low-density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma-bearing mice.
J Pharm Pharmacol. 2014 Dec;66(12):1698-709. doi: 10.1111/jphp.12296. Epub 2014 Aug 17.
本文引用的文献
1
Monoclonal antibody covalently coupled with fatty acid. A reagent for in vitro liposome targeting.
J Biol Chem. 1980 Sep 10;255(17):8015-8.
2
Differential cytotoxicity of daunomycin in tumour cells is related to glutathione-dependent hydrogen peroxide metabolism.
Biochem J. 1981 Jan 15;194(1):369-72. doi: 10.1042/bj1940369.
3
Targeting of lipid vesicles: specificity of carbohydrate receptor analogues for leukocytes in mice.
Proc Natl Acad Sci U S A. 1980 Aug;77(8):4430-4. doi: 10.1073/pnas.77.8.4430.
4
Base specificity in the interaction of polynucleotides with antibiotic drugs.
Science. 1965 Sep 10;149(3689):1259-63. doi: 10.1126/science.149.3689.1259.
5
DNA complexing antibiotics: daunomycin, adriamycin and their derivatives.
Arzneimittelforschung. 1975 Mar;25(3):368-74.
6
Effects of adriamycin on surface properties of sarcoma 180 ascites cells.
Biochem Pharmacol. 1976 May 15;25(10):1227-31. doi: 10.1016/0006-2952(76)90374-9.
7
Factors affecting the encapsulation of drugs within liposomes.
Can J Physiol Pharmacol. 1979 May;57(5):535-9. doi: 10.1139/y79-081.
8
Liposome-incorporated corticosteroids: I. The interaction of liposomal cortisol palmitate with inflammatory synovial membrane.
Br J Exp Pathol. 1979 Apr;60(2):142-50.
9
Biological and physio-chemical properties of some N-aceyl-daunorubicin derivatives.
Biochem Pharmacol. 1979;28(2):335-7. doi: 10.1016/0006-2952(79)90525-2.
Zotero 插件